Navigation Links
VIDEO from Medialink and Siemens: The Next Generation Allergy Test - Nothing to Sneeze At
Date:9/19/2007

NEW YORK, Sept. 19 /PRNewswire/ -- If you've been experiencing watery eyes and excessive sneezing, you're not alone. Allergy rates are on the rise in the U.S., with an estimated 50 million Americans suffering. One side effect -- Americans are buying antihistamines to the tune of 3 billion dollars a year, often without knowing which allergies are actually causing their symptoms. Doctors say in-vitro blood tests, the latest generation of allergy tests, can help take out the guess work out of diagnosing and treating allergies.

(See video from Siemens (NYSE: SI) at: http://media.medialink.com/WebNR.aspx?story=33860)

Unlike the skin prick tests of the past, which can take an hour-and-a-half to perform and require up to 150 injections, in-vitro tests like the 3G allergy tests require just one blood sample. Systems like the IMMULITE(R)2000 from Siemens are then able to test that sample for up to 420 specific allergens and allergy panels. Doctors say this testing method is more convenient, efficient and accurate, not to mention more comfortable for the patient. The tests can be performed in patients over the age of 3 months.

Registered journalists can access video, audio, text, graphics and photos for free and unrestricted use at http://www.mediaseed.tv.

09FF07-0008


'/>"/>
SOURCE Medialink and Siemens
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cut down TV and video games and you have less aggressive children.
2. Parents Should Beware of Violent Video Games
3. Children’s obesity linked to video game
4. Poland: Parental warning systems are likely to be adopted in video games.
5. Video Games, The Latest Craze Of American Adults
6. Interactive Video, Better Teaching Aid For Toddlers
7. Video Games Reduces Surgical Errors – A Stud
8. Fun And Cure With Video Games
9. Stroke Rehabilitation Through Modified Video Games
10. Videoconferencing, an impetus to Pediatric Oncology
11. Free Online Educational Videos for People with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... , ... May 24, 2017 , ... ... of ExtraHop to its solutions portfolio. ExtraHop delivers an analytics-first approach, layered with ... every IT system, from the datacenter to the cloud to the edge. Through ...
(Date:5/24/2017)... ... 24, 2017 , ... The CFOs included on this list ... in the nation and help their organizations navigate the challenges in healthcare today. ... in developing successful hospital and health system strategy. , Becker's Hospital Review has ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a ... today that its iClinic V12.2 solution has achieved approval from National Center for ... PCMH 2017 standards which emphasize team-based care with a significant focus on the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, May ... since 2009, according to a Workers Compensation Research Institute (WCRI) study, a contrast ... North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and medical ...
(Date:5/23/2017)... ... 2017 , ... London, May 23, 2017: Walter Schindler, the Founder and Managing ... Guest Speaker and Contributor to a weeklong series of classes, meetings, field trips and ... , Walter Schindler and SAIL Capital have received an increasing number ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)... -- Bayer announced today that the latest research from across ... 53 rd Annual Meeting of the American Society ... Chicago . The ... and thyroid cancers, as well as lymphomas, and includes ... of copanlisib in patients with relapsed or refractory follicular ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: